Walmart joins blockchain collaborative to track prescription drugs

Walmart is the latest company to join the MediLedger consortium, a collaborative working to build a blockchain that will be designed to track and verify prescription drugs, according to Yahoo Finance.

Current partners in the blockchain collaborative including Pfizer, McKesson, AmerisourceBergen and Cardinal Health. The blockchain network is built on Etherum blockchain.

MediLedger is scheduled to release a pilot project in collaboration with the FDA later this month. The FDA is on pace to launch a digital system to track pharmaceuticals by 2023. To make this happen, the FDA is considering various options, including blockchain technology initiatives like MediLedger.

This is Walmart's second blockchain initiative. Walmart is already part of IBM's Food Trust, a supply chain for food that is build on the Hyperledger Fabric blockchain.

More articles on health IT:

More devices don't equal better outcomes: Why hospitals should focus on social determinants of health
5 most popular health IT stories in May
3 ways blockchain smart contracts can be leveraged in healthcare

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars